97 related articles for article (PubMed ID: 7893480)
1. Assay of estrogen and progesterone receptors in small samples of breast cancer: I. Mathematical analysis of total binding data.
Piantanelli L; Rossolini G; Viticchi C; Basso A
Boll Soc Ital Biol Sper; 1994; 70(8-9):221-7. PubMed ID: 7893480
[TBL] [Abstract][Full Text] [Related]
2. Assay of estrogen and progesterone receptors in small samples of breast cancer: II. The conventional procedure compared to the mathematical one.
Viticchi C; Basso A; Piantanelli L; Zaia A
Boll Soc Ital Biol Sper; 1994; 70(8-9):229-34. PubMed ID: 7893481
[TBL] [Abstract][Full Text] [Related]
3. Histochemical determination of estrogen and progesterone binding in fine needle aspirates of breast cancer. Correlation with conventional biochemical assays.
Curtin CT; Pertschuk LP; Mitchell V
Acta Cytol; 1982; 26(6):841-6. PubMed ID: 6961721
[TBL] [Abstract][Full Text] [Related]
4. [Determination of estradiol and progesterone receptors in breast cancer. Determination by Scatchard's method or by a single point test].
Peyrat JP; Fournier J
Bull Cancer; 1987; 74(6):647-8. PubMed ID: 3435790
[No Abstract] [Full Text] [Related]
5. [Western blot analysis and flow cytometric analysis of estrogen and progesterone receptors in fixed breast cancer cells].
Tao DD; Jiang M; Wu JH; Feng YD; Gong JP
Ai Zheng; 2004 Mar; 23(3):339-41. PubMed ID: 15025971
[TBL] [Abstract][Full Text] [Related]
6. Detection of oestrogen and progesterone receptor expression in breast tumors by semiquantitative PCR.
Hackl T; Zickl M; Dobianer K; Hruza C; Czerwenka K; Spona J
Anticancer Res; 1998; 18(2A):839-42. PubMed ID: 9615729
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical determination of estrogen and progesterone receptors and flow cytometric DNA analysis of breast cancer on fine needle aspirates.
Marrazzo A; Russo A; Bazan V; Taormina P; Lupo F; Bazan P
Anticancer Res; 1993; 13(6B):2435-40. PubMed ID: 8135480
[TBL] [Abstract][Full Text] [Related]
8. [Hormone receptors of human breast cancer. I. Determination of estrogen and progesterone receptors in human breast cancer].
Zhang HY
Zhonghua Zhong Liu Za Zhi; 1983 May; 5(3):168-71. PubMed ID: 6628170
[No Abstract] [Full Text] [Related]
9. Seasonal variation in estrogen and progesterone receptor levels in breast cancer--a factor in data interpretation.
Vyzula R; Zaloudík J; Dusek L; Vermousek I
Neoplasma; 2001; 48(1):19-25. PubMed ID: 11327533
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
[TBL] [Abstract][Full Text] [Related]
11. [Quantitative determination of steroid hormone receptors in breast cancer tissue outside tumor centers].
Prechtel D; Prechtel K
Pathologe; 1993 Jan; 14(1):16-20. PubMed ID: 8451222
[No Abstract] [Full Text] [Related]
12. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
[TBL] [Abstract][Full Text] [Related]
13. [A comparative study of hormone receptors in breast cancer with quantitative immunocytochemistry and biochemistry].
Marcot I; Migeon C; Parache RM; Marchal S; Virion JM
Bull Cancer; 1997 Jun; 84(6):613-8. PubMed ID: 9295864
[TBL] [Abstract][Full Text] [Related]
14. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
15. [Expression of steroid receptors and DNA synthesis in male breast cancer].
Petroni S; Mangia A; D'Amico C; Simone G
Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
[TBL] [Abstract][Full Text] [Related]
16. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
17. ErbB2 assay in breast cancer: possibly improved clinical information using a quantitative method.
Dittadi R; Brazzale A; Pappagallo G; Salbe C; Nascimben O; Rosabian A; Gion M
Anticancer Res; 1997; 17(2B):1245-7. PubMed ID: 9137481
[TBL] [Abstract][Full Text] [Related]
18. [Current questions about estrogen receptor determination and hormone dependence (does estrogen receptor positivity equal estrogen dependence?)].
Kahán Z
Orv Hetil; 1996 Oct; 137(42):2305-8. PubMed ID: 8992428
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay.
Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R
Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392
[TBL] [Abstract][Full Text] [Related]
20. Basic and clinical relevance of hormonal influence in breast cancer.
Pollow K; Grill HJ; Kreienberg R; Hoffmann G; Beck T; Schmidt-Gollwitzer K; Manz B
Recent Results Cancer Res; 1990; 118():196-224. PubMed ID: 2236839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
